These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24739345)

  • 1. Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
    George MD; Asmuth DM
    Curr Opin Infect Dis; 2014 Jun; 27(3):275-81. PubMed ID: 24739345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S; George MD; Bäumler AJ
    Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
    Costiniuk CT; Angel JB
    Mucosal Immunol; 2012 Nov; 5(6):596-604. PubMed ID: 22929559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17, gut, and HIV: therapeutic implications.
    Hunt PW
    Curr Opin HIV AIDS; 2010 Mar; 5(2):189-93. PubMed ID: 20543599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.
    Cao W; Mehraj V; Vyboh K; Li T; Routy JP
    AIDS Rev; 2015; 17(3):135-46. PubMed ID: 26450802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.
    Evering TH; Mehandru S; Racz P; Tenner-Racz K; Poles MA; Figueroa A; Mohri H; Markowitz M
    PLoS Pathog; 2012 Feb; 8(2):e1002506. PubMed ID: 22319447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.
    Tincati C; Douek DC; Marchetti G
    AIDS Res Ther; 2016; 13():19. PubMed ID: 27073405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent inflammation in HIV infection: established concepts, new perspectives.
    Nasi M; Pinti M; Mussini C; Cossarizza A
    Immunol Lett; 2014 Oct; 161(2):184-8. PubMed ID: 24487059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].
    Vergnon-Miszczycha D; Lucht F; Roblin X; Pozzetto B; Paul S; Bourlet T
    Med Sci (Paris); 2015 Dec; 31(12):1092-101. PubMed ID: 26672662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
    Asmuth DM; Ma ZM; Mann S; Knight TH; Yotter T; Albanese A; Melcher GP; Troia-Cancio P; Hayes T; Miller CJ; Pollard RB
    AIDS; 2012 Aug; 26(13):1625-34. PubMed ID: 22820612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation.
    Wang H; Kotler DP
    Curr Opin HIV AIDS; 2014 Jul; 9(4):309-16. PubMed ID: 24871087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
    Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P
    J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of HIV in the gastrointestinal tract.
    Dandekar S
    Curr HIV/AIDS Rep; 2007 Feb; 4(1):10-5. PubMed ID: 17338855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection and the gastrointestinal immune system.
    Brenchley JM; Douek DC
    Mucosal Immunol; 2008 Jan; 1(1):23-30. PubMed ID: 19079157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines at mucosal barriers and their impact on HIV infection.
    Rancez M; Couëdel-Courteille A; Cheynier R
    Cytokine Growth Factor Rev; 2012; 23(4-5):233-43. PubMed ID: 22728258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of gut mucosa and mesenteric lymph nodes in simian immunodeficiency virus-infected macaques with divergent disease course.
    George MD; Verhoeven D; McBride Z; Dandekar S
    J Med Primatol; 2006 Aug; 35(4-5):261-9. PubMed ID: 16872289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.
    Chege D; Sheth PM; Kain T; Kim CJ; Kovacs C; Loutfy M; Halpenny R; Kandel G; Chun TW; Ostrowski M; Kaul R;
    AIDS; 2011 Mar; 25(6):741-9. PubMed ID: 21378536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.